What are the recommended dosing guidelines for promethazine-dextromethorphan (Promethazine DM) in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Promethazine DM Dosing

For adults, the recommended dose of promethazine-dextromethorphan (Promethazine DM) oral solution is 5 mL (containing 6.25 mg promethazine and 15 mg dextromethorphan) every 4–6 hours, not exceeding 30 mL in 24 hours. 1

Pediatric Dosing by Age

The FDA-approved dosing for Promethazine DM oral solution varies by age group and is contraindicated in children under 2 years of age due to the risk of fatal respiratory depression: 1

  • Children 2 to under 6 years: 1.25–2.5 mL every 4–6 hours, not exceeding 10 mL in 24 hours 1
  • Children 6 to under 12 years: 2.5–5 mL every 4–6 hours, not exceeding 20 mL in 24 hours 1
  • Children 12 years and older (adolescents): 5 mL every 4–6 hours, not exceeding 30 mL in 24 hours 1

Critical Safety Warnings

Black Box Warning for Pediatric Use

Promethazine is absolutely contraindicated in children under 2 years of age because postmarketing reports have documented fatal respiratory depression in this population. 1 Even when used in children 2 years and older, the lowest effective dose should be employed, and concomitant administration of other respiratory depressants (opioids, benzodiazepines, alcohol) must be avoided. 1

Respiratory Depression Risk

Promethazine may cause potentially fatal respiratory depression and should be avoided in patients with compromised respiratory function, including those with COPD or sleep apnea. 1 The sedative and respiratory depressant effects are amplified when combined with other CNS depressants such as alcohol, narcotics, benzodiazepines, or barbiturates. 1

Administration Precautions

When promethazine is given intravenously (as a single agent, not in the DM combination), it must be infused slowly at no more than 25 mg/min to minimize hypotension risk. 2, 3 The usual IV dose for promethazine alone is 12.5–25 mg, with a total dose range of 25–50 mg when used as an adjuvant. 3 However, the Promethazine DM oral solution formulation discussed here is for oral use only. 1

Recent safety alerts emphasize that injectable promethazine carries rare but serious risks of limb-threatening complications from extravasation or inadvertent intra-arterial injection, and intramuscular administration is now preferred over intravenous when parenteral dosing is necessary. 4

Dosing Considerations for Specific Populations

Elderly Patients

In geriatric patients, promethazine should be started at the low end of the dosing range (6.25 mg for antiemetic use) because sedating drugs may cause confusion and over-sedation in the elderly. 1 Research demonstrates that 6.25 mg IV promethazine is as effective as 12.5 mg for treating nausea and vomiting in hospitalized elderly patients, with significantly fewer adverse drug reactions. 5

Pregnancy

When promethazine is used for nausea and vomiting in pregnancy (as a single agent, not combined with dextromethorphan), the recommended dose is 12.5–25 mg every 4–8 hours via oral, intramuscular, or intravenous routes. 6 Promethazine is classified as Pregnancy Category C and should only be used when potential benefits justify fetal risks. 1

Drug Interactions

Promethazine DM is absolutely contraindicated with monoamine oxidase inhibitors (MAOIs) because dextromethorphan combined with MAOIs has caused hyperpyrexia, hypotension, and death. 1 When promethazine is given with narcotics, the narcotic dose should be reduced by one-quarter to one-half; when given with barbiturates, the barbiturate dose should be reduced by at least one-half. 1

Mechanism and Pharmacokinetics

Promethazine is a first-generation phenothiazine antihistamine with H1-receptor antagonist, sedative, antiemetic, and anticholinergic properties. 2, 3 Clinical effects appear within 5 minutes of IV administration, with a duration of action of 4–6 hours and a plasma half-life of 9–16 hours. 2, 3 Dextromethorphan is a non-sedating opioid derivative that acts centrally to suppress the cough reflex. 7, 8

Common Pitfalls to Avoid

  • Never use promethazine in children under 2 years of age under any circumstances 1
  • Do not combine with MAOIs due to life-threatening interactions with dextromethorphan 1
  • Avoid combining with other CNS depressants without dose reduction, as additive sedation and respiratory depression can occur 1
  • Do not use epinephrine to treat promethazine-associated hypotension, as promethazine may reverse epinephrine's vasopressor effect 1
  • Counsel patients to avoid driving or operating machinery until they know how the medication affects them, as promethazine impairs mental and physical abilities 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.